Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
metabolic disorder |
| gptkbp:alsoKnownAs |
gptkb:type_2_diabetes
gptkb:T2DM |
| gptkbp:cause |
combination of genetic and environmental factors
|
| gptkbp:characterizedBy |
insulin resistance
high blood sugar relative lack of insulin |
| gptkbp:complication |
gptkb:cardiovascular_disease
stroke chronic kidney disease nerve damage retinopathy foot ulcers |
| gptkbp:diagnosedBy |
gptkb:oral_glucose_tolerance_test
HbA1c test fasting blood glucose test |
| gptkbp:firstDescribed |
1936
|
| gptkbp:frequency |
over 400 million people worldwide
|
| https://www.w3.org/2000/01/rdf-schema#label |
diabetes mellitus type 2
|
| gptkbp:ICD-10_code |
E11
|
| gptkbp:managedBy |
gptkb:food
gptkb:drug exercise weight loss |
| gptkbp:mortalityRate |
major cause of premature death
|
| gptkbp:onset |
usually adulthood
can occur in children |
| gptkbp:prevalence |
increasing worldwide
most common form of diabetes |
| gptkbp:relatedTo |
gptkb:gestational_diabetes
gptkb:prediabetes diabetes mellitus type 1 |
| gptkbp:riskFactor |
family history
obesity ethnicity physical inactivity older age unhealthy diet |
| gptkbp:symptom |
fatigue
blurred vision frequent urination increased thirst slow healing of wounds increased hunger |
| gptkbp:treatment |
gptkb:metformin
gptkb:insulin gptkb:GLP-1_receptor_agonists gptkb:SGLT2_inhibitors lifestyle modification oral hypoglycemic agents sulfonylureas |
| gptkbp:bfsParent |
gptkb:insulin
gptkb:diabetic_macular_edema gptkb:Lantus |
| gptkbp:bfsLayer |
6
|